Supernus Pharmaceuticals | SUPN - EPS Earnings Per Share


Supernus Pharmaceuticals reported $0.6 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.59 -0.80 Nov/10
FY2026Q2 Jun/2026 0.43 0.40 Aug/11
FY2026Q1 Mar/2026 0.60 0.52 -0.21 May/05
FY2025Q4 Dec/2025 -0.07 0.41 0.27 Feb/24
FY2025Q3 Sep/2025 -0.80 0.37 0.69 Nov/04




Eps Change Date
Abbott USD 1.31 0.16 Jun/2026
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
Aurora Cannabis CAD -0.13 0.51 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Canopy Growth CAD -0.4 0.35 Mar/2026
Cara Therapeutics USD -0.59 4.45 Sep/2025
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Eisai JPY -11.53 72.47 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Novo Nordisk DKK 10.91 4.87 Mar/2026
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026